| Announce Date | 08/05/2025 |
| EPS Normalized Actual | $-0.57 (Beat by $0.36) |
| EPS GAAP Actual | $-0.57 (Beat by $0.36) |
| Revenue Actual | $0.063941B |
| Revenue Surprise | Beat by $63.941M |
| Announce Date | 12/30/2025 (Pre-Market) |
| EPS Normalized Estimate | $-1.375 |
| EPS GAAP Estimate | $-1.375 |
| Revenue Estimate | $0.11593B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2027 | 0 | INF | 0 | 0 | 0 |
| Dec 2026 | 0 | INF | 0 | 0 | 0 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ2 2025 (Jun 2025) | -0.85 | 1.65 | 0.063941B | 100% | -81.31M |
| FQ1 2025 (Mar 2025) | -0.84 | 0.55 | 0.072363B | 100% | -45.57M |
| FQ4 2024 (Dec 2024) | -5.04 | -3.3138 | 0.086374B | 100% | -19.69M |
| FQ3 2024 (Sep 2024) | -1.75 | -0.17 | 0.102193B | 100% | -12.07M |
| FQ4 2019 (Dec 2019) | 1.3 | 1.3 | 0.165108B | 100% | 165.11M |
| FQ1 2020 (Mar 2020) | -7 | -7 | 0.169336B | 100% | 169.34M |
| FQ2 2020 (Jun 2020) | -2.1 | -2.1 | 0.218484B | 100% | 218.48M |
| FQ3 2020 (Sep 2020) | 2.5 | 2.5 | 0.251479B | 100% | 251.48M |
FQ4 Announce Date
12/30/2025 (Pre-Market)
Consensus EPS Estimates
-1.375
Consensus Revenue Estimates
0.11593B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2026 (Dec 2026) | -1.09 | -- | -1.10625 | -1.07375 | 1 |
| FQ3 2026 (Sep 2026) | -1.32 | -- | -1.3956 | -1.2444 | 1 |
| FQ2 2026 (Jun 2026) | -1.32 | 35.61 | -1.3956 | -1.2444 | 1 |
| FQ1 2026 (Mar 2026) | -0.6 | -40 | -0.60894 | -0.59106 | 1 |
| FQ4 2025 (Dec 2025) | -1.375 | -266.55 | -1.375 | -1.375 | 0 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2026 (Dec 2026) | 0.05B | -- | 0.04B | 0.05B | 1 |
| FQ3 2026 (Sep 2026) | 0.05B | -- | 0.04B | 0.05B | 1 |
| FQ2 2026 (Jun 2026) | 0.05B | -39 | 0.04B | 0.05B | 1 |
| FQ1 2026 (Mar 2026) | 0.05B | -43.58 | 0.05B | 0.05B | 1 |
| FQ4 2025 (Dec 2025) | 0.12B | 25.49 | 0.12B | 0.12B | 0 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
4
EPS # of Misses
4
EPS # of in-lines
0
Revenue # of Beats
4
Revenue # of Misses
4
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ2 2025 (Jun 2025) | -2.5 | -0.85 | 1.65 | -194.12% |
| FQ1 2025 (Mar 2025) | -1.39 | -0.84 | 0.55 | -65.48% |
| FQ4 2024 (Dec 2024) | -1.7262 | -5.04 | -3.3138 | 65.75% |
| FQ3 2024 (Sep 2024) | -1.58 | -1.75 | -0.17 | 9.71% |
| FQ4 2019 (Dec 2019) | 1.3 | 1.3 | 100% | |
| FQ1 2020 (Mar 2020) | -7 | -7 | 100% | |
| FQ2 2020 (Jun 2020) | -2.1 | -2.1 | 100% | |
| FQ3 2020 (Sep 2020) | 2.5 | 2.5 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ2 2025 (Jun 2025) | $0.15B | $0.06B | $-81.31M | -127.16% |
| FQ1 2025 (Mar 2025) | $0.12B | $0.07B | $-45.57M | -62.97% |
| FQ4 2024 (Dec 2024) | $0.11B | $0.09B | $-19.69M | -22.8% |
| FQ3 2024 (Sep 2024) | $0.11B | $0.1B | $-12.07M | -11.81% |
| FQ4 2019 (Dec 2019) | $0B | $0.17B | $165.11M | 100% |
| FQ1 2020 (Mar 2020) | $0B | $0.17B | $169.34M | 100% |
| FQ2 2020 (Jun 2020) | $0B | $0.22B | $218.48M | 100% |
| FQ3 2020 (Sep 2020) | $0B | $0.25B | $251.48M | 100% |